Full Year Results, Appendix 4E and Analysts Presentation
Filed with ASX · · 144 pages · English
CSL Limited (ASX:CSL) today announced a net profit after tax (NPAT) of US$1,216 million for the twelve months ended 30 June 2013, up US$192 million or 19% on a reported basis when compared to the prior comparable period (PCP). The result included an unfavourable foreign exchange impact of US$18 million. On a constant currency1 basis, net profit after tax grew 21%, slightly ahead of guidance. Earni
Earlier from CSL
- CSL Settles US Class Action and Updated Profit Guidance
- Half Yearly Report and Accounts
- Appendix 4E, FY Results and Analysts Presentation
- Changes relating to buy-back - Appendix 3D
- IDELVION(R) (rFIX-FP) - FDA approval
Later from CSL
- New US$500 million Private Placement
- Appointment of Paul Perreault as Executive Director
- Announcement of buy-back
- Chairmans and MDs address to shareholders
- Recombinant Technologies
Follow CSL into a list and get an email when it puts out news.
Follow CSL